Analysis of the Global Biologics API Market
|出版商||Frost & Sullivan||商品編碼||366642|
|出版日期||內容資訊||英文 53 Pages
Redefining the Future of Biologics through Target-specific Drugs and Novel Technologies
This study provides an insight into the global biologics active pharmaceutical ingredients (API) market. According to the US FDA, “Biological products, or biologics, are medical products made from a variety of natural sources (human, animal, or microorganism). Biologics are intended to treat diseases & medical conditions and prevent or diagnose diseases.” Biologic drugs are significantly derived from monoclonal antibodies, recombinant proteins, vaccines, and others (e.g., cell therapy, gene therapy, antibody drug conjugates). In this study, drivers, restraints, and the competitive landscape as well as outsourcing and market and technology trends are discussed. Estimates and forecasts for the global market are provided from 2016 to 2020.